Results 161 to 170 of about 364,761 (266)

Development and validation of a neural network survival prediction model for ischemic heart disease. [PDF]

Cardiovasc Diabetol
Holm PC, Haue AD, Westergaard D, Röder T, Banasik K, Tragante V, Johansen CH, Christensen AH, Thomas L, Nøst TH, Skogholt AH, Iversen KK, Pedersen F, Høfsten DE, Pedersen OB, Ostrowski SR, Ullum H, Svendsen MN, Gjødsbøl IM, Gudnason T, Guðbjartsson DF, Helgadottir A, Hveem K, Køber LV, Holm H, Stefansson K, Brunak S, Bundgaard H.   +27 more
europepmc   +1 more source

Systemic Bevacizumab for Severe Bleeding From Acquired Gastrointestinal Vascular Malformations

American Journal of Hematology, EarlyView.
Targeted antiangiogenic therapy with systemic bevacizumab for bleeding from acquired GI VMs was found to be safe and effective for chronic and severe bleeding from acquired vascular malformations due to idiopathic angiodysplasia, chronic liver disease, and deficiencies of von Willebrand factor, in a patient population comprised mostly of heavily ...
Nardeen E. Ayad, Jacob R. Anderson, Bimalangshu Dey, Rebecca Karp Leaf, Andrew B. Song, Hanny Al‐Samkari   +5 more
wiley   +1 more source

Modifying effect of statin use on the association between nitrogen dioxide exposure and ischemic heart disease in patients with hypertension. [PDF]

Clin Hypertens
Park H, Jang H, Lee H, Kim C, Cho J.
europepmc   +1 more source

The Risk of Cardiovascular Diseases for Shift Workers in the Prospective Heinz Nixdorf Recall Study

American Journal of Industrial Medicine, EarlyView.
ABSTRACT Background Shift work can disrupt circadian rhythms and is postulated to play a role in cardiovascular diseases (CVD). In the German prospective population‐based Heinz Nixdorf Recall Study, we analyzed longitudinal associations between shift work and night‐shift work with CVD.
Katharina Wichert, Sylvia Rabstein, Raimund Erbel, Lewin Eisele, Marina Arendt, Nico Dragano, Karl‐Heinz Jöckel, Thomas Behrens   +7 more
wiley   +1 more source

Bioengineered Cellular and Acellular Therapies for Ischemic Heart Disease in Clinically Relevant Models. [PDF]

Bioengineering (Basel)
Muir KC, Zheng C, Yalamanchili K, Reddy R, Joseph A, Hamze J, Harris DD, Sellke FW.   +7 more
europepmc   +1 more source

Electrocardiographic and Skin Manifestations of Turner Syndrome: Association With Cardiovascular Disease

American Journal of Medical Genetics Part A, EarlyView.
ABSTRACT Congenital heart disease (CHD) and dermatologic conditions such as lymphedema and acquired melanocytic nevi (AMN) are common in Turner Syndrome (TS). We hypothesized that abnormalities of cranial neural crest cell derivatives drive the skin and heart manifestations of TS. We conducted joint cardiac and skin examinations of volunteers at a 2023
Sarah Elsaim, Brett Vernier, Van Thi Thanh Truong, Riya T. Patel, Matthew Brown, Martin Chacon Portillo, Megan Rogge, David Rodriguez‐Buritica, Siddharth K. Prakash   +8 more
wiley   +1 more source

Sex Differences in the Growing Challenge of Ischemic Heart Disease in South Asia. [PDF]

JACC Asia
Hamatani Y, Pabon MA, Wang X.
europepmc   +1 more source

A Novel NR3C1 Frameshift Variant Associated With Familial Glucocorticoid Resistance Syndrome: An Integrated Analysis of Steroid Profiling and Structural Modeling

American Journal of Medical Genetics Part A, EarlyView.
ABSTRACT Glucocorticoid resistance syndrome (GRS) is a rare hereditary disorder caused by pathogenic variants in NR3C1, characterized by marked phenotypic heterogeneity and frequent misdiagnosis as primary aldosteronism or subclinical Cushing's syndrome.
Sufang Yun, Zhifeng Zhu, Fengye Zhou, Ying Liu, Chunfang Liang, Haitao Ju, Lin Lu, Zhaoli Yan   +7 more
wiley   +1 more source

Global trends and research hotspots in coronary revascularization for ischemic heart disease: a bibliometric analysis (2005-2024). [PDF]

J Cardiothorac Surg
He JM, Kong YQ, Wang DJ, Feng XH, Dong Y, Yin ZH, Zhou D.   +6 more
europepmc   +1 more source